Jazz Pharmaceuticals plc (JAZZ) › EPS (Diluted)Jazz Pharmaceuticals plc (JAZZ) — EPS (Diluted)Annual figures by period end, from SEC filings.2009-12-31: $-0.232010-12-31: $0.832011-12-31: $2.672012-12-31: $4.792013-12-31: $3.512014-12-31: $0.932015-12-31: $5.232016-12-31: $6.412017-12-31: $7.962018-12-31: $7.302019-12-31: $9.092020-12-31: $4.222021-12-31: $-5.522022-12-31: $-3.582023-12-31: $6.102024-12-31: $8.652025-12-31: $-5.84$-5.842009-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$-5.84-167.5%2026-02-24From 2025-01-012024-12-31$8.65+41.8%2026-02-24From 2024-01-012023-12-31$6.10—2026-02-24From 2023-01-012022-12-31$-3.58—2025-02-26From 2022-01-012021-12-31$-5.52-230.8%2024-02-28From 2021-01-012020-12-31$4.22-53.6%2023-03-01From 2020-01-012019-12-31$9.09+24.5%2022-03-01From 2019-01-012018-12-31$7.30-8.3%2021-02-23From 2018-01-012017-12-31$7.96+24.2%2020-02-25From 2017-01-012016-12-31$6.41+22.6%2019-02-26From 2016-01-012015-12-31$5.23+462.4%2018-02-27From 2015-01-012014-12-31$0.93-73.5%2017-02-28From 2014-01-012013-12-31$3.51-26.7%2016-02-23From 2013-01-012012-12-31$4.79+79.4%2015-02-24From 2012-01-012011-12-31$2.67+221.7%2014-02-25From 2011-01-012010-12-31$0.83—2013-02-26From 2010-01-012009-12-31$-0.23—2012-02-28From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)